Table 2.

Age and semi-quantitative values in patients with and without large vessel vasculitis (LVV). Data are provided as mean ± SD. Area under the curve (AUC) is provided with 95% confidence intervals (CI)

	SA vessels vasculitis				TA vasculitis				IA vessels vasculitis
	Pos (n = 38)	Neg (n = 62)	p	AUC (95% CI)	Pos (n = 42)	Neg (n = 58)	p	AUC (95% CI)	Pos (n = 26)	Neg (n = 74)	p	AUC (95% CI)
Age (years)	69.3 ± 9.34	66.5 ± 11.7	0.283	-	68.5 ± 9.97	66.9 ± 11.5	0.546	-	69.2 ± 8.18	67.0 ± 11.7	0.563	-
Male gender, n (%)	13 (34.2)	28 (45.2)	0.301	-	13 (31.0)	28 (48.3)	0.101	-	8 (30.8)	33 (44.6)	0.253	-
SUVmax	3.48 ± 1.53	1.89 ± 0.57	< 0.01	0.81 (0.73–0.90)	4.62 ± 1.69	2.50 ± 0.97	< 0.01	0.88 (0.81–0.95)	4.02 ± 1.41	2.95 ± 1.47	< 0.01	0.89 (0.83–0.96)
SUVmean	1.92 ± 0.67	1.28 ± 0.39	< 0.01	0.76 (0.67–0.86)	2.12 ± 0.61	1.60 ± 0.62	< 0.01	0.78 (0.69–0.87)	2.04 ± 0.62	1.73 ± 0.66	0.012	0.79 (0.70–0.88)
SUVpeak	2.32 ± 0.87	1.57 ± 0.45	< 0.01	0.74 (0.64–0.84)	3.19 ± 0.96	2.06 ± 0.73	< 0.01	0.85 (0.77–0.93)	2.69 ± 0.82	2.26 ± 0.92	0.008	0.84 (0.77–0.92)
SUVmax/L-SUVmax	1.22 ± 0.61	0.60 ± 0.13	< 0.01	0.91 (0.85–0.97)	1.62 ± 0.61	0.77 ± 0.19	< 0.01	0.95 (0.92–0.99)	1.45 ± 0.56	0.94 ± 0.45	< 0.01	0.98 (0.96–1.00)
SUVmax/L-SUVmean	1.61 ± 0.72	0.80 ± 0.19	< 0.01	0.90 (0.84–0.96)	2.07 ± 0.75	1.01 ± 0.26	< 0.01	0.94 (0.90–0.99)	1.88 ± 0.68	1.23 ± 0.56	< 0.01	0.98 (0.95–1.00)

SUV Standardized uptake value, L-SUV to-liver normalized standardized uptake value, SA supra-aortic vessels, TA thoracic aorta, IA infra-aortic vessels, Pos. patients with LVV, Neg. patients without LVV